These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1301660)

  • 1. [The relationship of the antigenic characteristics of the tick-borne encephalitis virus to the level of the protective activity of inactivated cultured vaccines].
    Vorob'eva MS; Rasshchepkina MN
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):35-7. PubMed ID: 1301660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
    Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus].
    Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA
    Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An assessment of the immunoepidemiological efficacy of a liquid cultured killed vaccine against tick-borne encephalitis virus strain 205 in the Maritime Territory].
    Leonova GN; Liubimova NB; Sergeev GA; Muratkina SM; Krugliak SP; Bobkov AV; Bondarenko SI; Tutubalina GN; Beliaev MM
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Feb; (2):43-6. PubMed ID: 1441813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with inactivated tick-borne encephalitis virus and the antigenic peptide 89-119 protects mice against intraperitoneal challenge.
    Goncharova E; Ryzhikov E; Poryvaev V; Bulychev L; Karpyshev N; Maksyutov A; Ryzhikov AB
    Int J Med Microbiol; 2006 May; 296 Suppl 40():195-201. PubMed ID: 16545605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The protective activity of preparations made from the tick-borne encephalitis virus grown using different cell cultures].
    El'bert LB; Vorovich MF; Terletskaia EN; Lisitsina EA; Atanadze SN; Sidorovich IG; Khozinskiĭ VV; Tugizov ShM; Kushch AA; Khapchaev IuKh
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Jan; (1):25-8. PubMed ID: 1414102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine.
    Klockmann U; Bock HL; Franke V; Hein B; Reiner G; Hilfenhaus J
    J Biol Stand; 1989 Oct; 17(4):331-42. PubMed ID: 2613707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subunit immunogen of the tick-borne encephalitis virus. The immunological characteristics of glycoprotein V3 from 2 antigenic types of tick-borne encephalitis virus].
    Chumakov MP; Rubin SG; Kusov IuIu; Semashko IV; Sal'nikov IaA
    Vopr Virusol; 1984; 29(6):701-6. PubMed ID: 6528577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].
    Popov OV; Sumarokov AA; Shkol'nik RIa; El'bert LB; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):34-9. PubMed ID: 3898672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative comparison of the cross-protection induced by tick-borne encephalitis virus vaccines based on European and Far Eastern virus subtypes.
    Fritz R; Orlinger KK; Hofmeister Y; Janecki K; Traweger A; Perez-Burgos L; Barrett PN; Kreil TR
    Vaccine; 2012 Feb; 30(6):1165-9. PubMed ID: 22178103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new prospective vaccine against tick-borne encephalitis].
    Chumakov MP; Rubin SG; Semashko IV; Karavanov AS; Avdeeva LI; Gagarina AV; Gambarian AS; Matrosovich MN; Mart'ianova LI; Mironova LL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):36-40. PubMed ID: 1858468
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
    Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
    Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
    J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.